A prospective single-blinded randomized multi-center clinical trial comparing the clinical efficacy and patient acceptability of open selective haemorrhoidopexy with stapled haemorrhoidopexy
- Conditions
- haemorrhoidspiles1000211210043413
- Registration Number
- NL-OMON39498
- Lead Sponsor
- Medisch Universitair Ziekenhuis Maastricht
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Withdrawn
- Sex
- Not specified
- Target Recruitment
- 186
Age above 18 years;Symptoms of haemorrhoidal disease 2nd to 4th grade. In case of 2nd grade haemorrhoidal disease, at least two attempts of Barron ligation must have preceded;Primary or recurrent haemorrhoidal disease;Written informed consent
Acute presentation (not elective)
Concurrent untreated or recurrent colorectal cancer
Concomitant anorectal diseases (fistula, abscess, fissure, polyps)
Prior endoscopic or surgical treatment of haemorrhoids within the past 6 months
Active inflammatory bowel disease
Previous major anorectal surgery
A history of faecal incontinence
Presence of severe rectal pain
ASA >3
The patient is uncooperative or is not capable to return for routine outpatient follow-up
On Coumarine derivate anticoagulation or history of coagulopathy
On immunosuppressant medication
Pregnancy
Non-consenting patients
Unwilling for randomisation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Primary endpoint is recurrence after two years.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Secondary Objectives:<br /><br>- Postoperative pain (VAS Score)<br /><br>- Early complications within 6 weeks postoperative: urinary retention,<br /><br>obstipation, incontinence<br /><br>- Complaints of urgency, tenesmus, pruritus<br /><br>- Patient satisfaction (VAS Score)<br /><br>- Operating time<br /><br>- Time of hospitalization<br /><br>- Re-admission to hospital<br /><br>- Time to return to work<br /><br>- Late complications: anal stenosis, impaired continence (Wexner Continence<br /><br>Score), recurrence<br /><br>- Re-treatment rates<br /><br>- Need for additional skin tag excision<br /><br>- Quality of life (SF-36 Health Survey questionnaire)<br /><br>- Cost effectiveness</p><br>